BioCentury
ARTICLE | Company News

Cellartis, Cellectis deal

November 7, 2011 8:00 AM UTC

Cellectis said shareholders at its general meeting approved the acquisition of Cellartis in a cash and stock deal valued at €27.3 million ($38.4 million). Cellartis shareholders will receive 1.9 milli...